Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma

Liver cancer has become the sixth most diagnosed cancer and the fourth leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) is responsible for up to 75–85% of primary liver cancers, and sorafenib is the first targeted drug for advanced HCC treatment. However, sorafenib resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jiao, Li, Jingjing, Wu, Liwei, Yu, Qiang, Ji, Jie, Wu, Jianye, Dai, Weiqi, Guo, Chuanyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336654/
https://www.ncbi.nlm.nih.gov/pubmed/32631382
http://dx.doi.org/10.1186/s13046-020-01629-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336654/
https://www.ncbi.nlm.nih.gov/pubmed/32631382
http://dx.doi.org/10.1186/s13046-020-01629-4

Ejemplares similares